Second orphan drug designation granted for pravibismane, in addition to the treatment of pulmonary infections in patients with cystic fibrosis Pravibismane demonstrated statistically significant in vivo efficacy against NTM in… Read More
BC health researchers now have a resource to improve collaboration with Indigenous communities. Indigenous researchers, Dr. Rheanna Robinson and Bev Best, led an environmental scan of Indigenous health research engagement… Read More
Health Canada’s acceptance of the submission follows that of the Ministry of Health, Labour and Welfare (WHLW) in Japan and approval by the US Food and Drug Administration (FDA) and… Read More
EP-104IAR demonstrates trends to reduction in joint inflammation and improvement in cartilage quality and morphology compared to placebo VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that it submitted its much-anticipated Investigational New Drug (“IND”) application… Read More
